1990

BioGaia Biologics

Peter Rothschild and Jan Annwall acquire the rights for the probiotic use of Lactobacillus reuteri and establish the company BioGaia Biologics.…

1991

Functional food

 Launch of the first functional food product containing BioGaia probiotics

1993

First patent

First patent on Lactobacillus reuteri granted

1994

ICA acquires the BRA trademark

ICA acquires the BRA trademark and concept

1995

First clinical trial

First Lactobacillus reuteri clinical trial in humans published

1996

Innovationsmarknaden

Introduction on IM, Innovationsmarknaden

1997

Multi Ferm

The fermentation facility Multi Ferm in Lund is acquired and becomes BioGaia Fermentation AB. The aim is to gain greater…

1998

O-list

Introduction on the O-list on the Stockholm Stock Exchange
, OMX NASDAQ

2000

First tablet in the world

BioGaia launches the first probiotic chewable tablet in the world

2001

Probiotic infant formula

The first probiotic infant formula with Lactobacillus reuteri is introduced to the market.*Patent for BioGaia Probiotic Straw (former LifeTop Straw), the first probiotic drinking…

2002

TwoPac

BioGaia Fermentation AB is sold at a profit. The BioGaia has acquired the necessary knowledge and can retain parts of…

2004

The world’s first probiotic drops

The world’s first probiotic drops for infants are launched. Over one billion daily doses of  Lactobacillus reuteri sold globally*

2005

Oral health products

Launch of the first probiotic oral health products for adults.

2006

BioGaia brand

Launch of the BioGaia brand
. The first year that the company makes a profit.

2007

Reduce crying time

Lactobacillus reuteri Protectis shown to significantly reduce crying time in infants with colic

2008

Over 50 studies

Over 50 studies with Lactobacillus reuteri in more than 4,000 subjects. Global agreement with Nestlé Nutrition for infant baby formula. BioGaia products sold…

2009

Probiotic oral rehydration solution

Launch of the BioGaia probiotic oral rehydration solution (ORS) containing Lactobacillus reuteri Protectis and zinc.* Net sales exceeds SEK 200 million

2010

Celebrates 20 years

Three billion doses sold globally. 80 studies carried out on over 5,000 individuals. BioGaia’s products sold in more than 60 countries. BioGaia celebrates 20 years…

2011

New products

Launch of oral health drops, drops with Vitamin D and digestive health tablet with strawberry flavour. Drops that can be…

2012

Collaboration with Nestlé

BioGaia extends and deepens its collaboration with Nestlé. TwoPac’s new production facility is completed. 108 clinical studies using BioGaia’s human strains…

2013

IBT + TwoPac

BioGaia aquires the remaining 50 per cent of TwoPac. Infant Bacterial Therapeutics is formed and is responsible for development of…

2014

MetaboGen

BioGaia invests in the Swedish research company MetaboGen

2015

Good Manufacturing Practice

BioGaia’s production facility TwoPac obtains GMP (Good Manufacturing Practice) certification

2016

IBT + Easy Dropper

Distribution of IBT:s shares to BioGaia’s shareholders. IBT is listed on First North. Launch of the packaging format Easy Dropper